中國神威藥業集團有限公司 (Incorporated in the Cayman Islands with limited liability)

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2019🗂️ Report periods on file: 2019

In its 2019 reporting, 中國神威藥業集團有限公司 (Incorporated in the Cayman Islands with limited liability) disclosed greenhouse gas emissions of 145.1K tCO2e/year. By scope: Scope 1: 111.1K tCO2e/year; Scope 2: 9.5K tCO2e/year; Scope 3: 24.6K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
145.1K tCO2e/year
2019
💧
Water Usage
350.6K tons/year
2019
♻️
Waste
15.6K tons/year
2019
⚙️
Energy Use
10.6M kWh/year
2019

📊 Emissions by Scope (2019)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).111.1K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.9.5K tCO2e/year
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).24.6K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🌱 ESG Focus Areas

Environmental ProtectionEmployee CareService QualityCommunity ParticipationCorporate GovernanceSustainable DevelopmentClimate ChangeUN Sustainable Development GoalsProduct Quality and SafetyResearch and DevelopmentGreen ProductionRisk Management

⚠️ Challenges & Risks +

  • Potential environmental risks to operations and supply chain due to extreme weather events
  • Potential social risks related to supply chain disruptions

📋 Report Information

Reporting Period: 2019
Frameworks: GRI Standards: Core option, Hong Kong Stock Exchange Listing Rules Appendix 27 ESG Reporting Guidelines